Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Contact your healthcare provider immediately if you accidentally take more than prescribed
Solmi M, Veronese N, Manzato E, et al
Gut mucosal repair: In the gastrointestinal system, BPC-157 promotes healing of ulcers, leaky gut, and mucosal damage
Common Side Effects Injection site reactions Headache Flushing Mild fluid retention Metabolic and Hormonal Considerations Potential alterations in glucose metabolism Elevated IGF-1 levels Theoretical risk of promoting tumor growth in predisposed individuals Key Limitation Most safety data comes from: Pediatric GH deficiency populations Adults with endocrine disorders There is limited long-term data in healthy, high-performing athletes
Australia's TGA has scheduled BPC-157 as Schedule 9 (Prohibited Substance) effective July 1, 2026
Thus, gMG can be caused by IgGs of different subclasses that bind different targets
